CN112294705B - Moisture mask and preparation method thereof - Google Patents

Moisture mask and preparation method thereof Download PDF

Info

Publication number
CN112294705B
CN112294705B CN201910704721.3A CN201910704721A CN112294705B CN 112294705 B CN112294705 B CN 112294705B CN 201910704721 A CN201910704721 A CN 201910704721A CN 112294705 B CN112294705 B CN 112294705B
Authority
CN
China
Prior art keywords
weight
sodium
phase
stirring
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910704721.3A
Other languages
Chinese (zh)
Other versions
CN112294705A (en
Inventor
孟宏
刘盼玉
曲召辉
刘有停
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taihe Kangmei Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Original Assignee
Taihe Kangmei Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taihe Kangmei Beijing Research Institute of Traditional Chinese Medicine Co Ltd filed Critical Taihe Kangmei Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Priority to CN201910704721.3A priority Critical patent/CN112294705B/en
Publication of CN112294705A publication Critical patent/CN112294705A/en
Application granted granted Critical
Publication of CN112294705B publication Critical patent/CN112294705B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88Polyamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9717Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a moisture mask. The facial mask disclosed by the invention is added with the compound humectant, and the components and the using amounts thereof (wt%) are as follows: 0.01-5.0 parts of sodium hyaluronate, 0.01-5.0 parts of carrageen crispus, 0.01-5.0 parts of sodium polyglutamate, 0.001-40.0 parts of glycerol, 0.01-2.0 parts of L-serine, 0.00-2.0 parts of L-proline, 0.0-0.3 part of L-glutamic acid, 0.001-15.0 parts of betaine, 0.0-20.0 parts of urea, 0.001-15.0 parts of sodium pyrrolidone carboxylate, 0.0-10.0 parts of trehalose, 0.0-1.0 part of preservative, 0.001-0.5 part of allantoin and 0.001-5.0 part of pH regulator. The moisture mask disclosed by the invention has film-forming property, can exert a lasting and efficient moisture-keeping effect, and has a wide application prospect.

Description

Moisture mask and preparation method thereof
Technical Field
The invention relates to the field of skin care products, and particularly relates to a mask with a long-acting moisturizing effect and a preparation method thereof.
Background
Facial masks are an important part of daily skin care products of people, and the moisturizing facial masks always occupy the primary position of facial mask products. Most of the moisturizing facial masks are used for directly supplementing skin moisture, maintaining the water content of stratum corneum, promoting the repair of skin barrier function and achieving the moisturizing effect.
The moisturizing effect of the moisturizing facial mask in the current market mainly depends on the following two ways: (1) the humectant in the product can combine moisture to introduce moisture into the crystalline structure of skin, and the components mainly comprise urea, trehalose, etc.; (2) the skin conditioner such as plant extract is added to improve physiological function of skin cells, thereby increasing skin moisture.
However, the various small molecule moisture-keeping components in these products only provide instant moisture-keeping effect, and the moisture content of skin is rapidly reduced after the mask cloth is removed, so that the long-term moisture-keeping effect cannot be achieved. The micromolecular humectant such as trehalose and sodium pyrrolidone carboxylate can rapidly permeate through the horny layer and be absorbed by the skin, the moisturizing effect of the micromolecular humectant can not be exerted on the horny layer for a long time, and the micromolecular humectant can not be continuously supplemented, so that the long-acting moisturizing effect of the product can not be achieved.
Based on the above problems, how to improve the moisturizing performance and the moisturizing efficiency of the small-molecule moisturizing agent in the mask product so that the moisturizing effect of the mask product is more durable and efficient becomes a technical problem to be solved by the technical personnel in the field.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide the moisturizing facial mask, which is formed by compounding three macromolecular carriers and simultaneously loads a micromolecular moisturizing agent, so that the micromolecular moisturizing agent is slowly released and efficiently utilized, and the moisturizing effect of the facial mask is effectively improved.
In order to realize the purpose, the invention adopts the following technical scheme:
in a first aspect, the invention provides a moisturizing mask, which comprises the following raw materials in parts by weight:
Figure 34985DEST_PATH_IMAGE001
according to the invention, the components and the dosage of the phase C compound humectant are as follows:
name of raw materials Addition amount (wt%)
Water (W) TO100
Hyaluronic acid sodium salt 0.01-5.00
Chondrus CRISPUS (Chondrus CRISPUS) 0.01-5.00
Polyglutamic acid sodium salt 0.01-5.00
Glycerol 0.001-40.00
L-serine 0.01-2.00
L-proline 0.00-2.00
L-glutamic acid 0.00-0.30
Betaine 0.001-15.00
Urea 0.00-20.00
Pyrrolidinone carboxylic acid sodium salt 0.001-15.00
Trehalose 0.00-10.00
Preservative 0.00-1.00
Allantoin 0.001-0.50
pH regulator 0.001-5.00,
According to the invention, three macromolecules of the polyglutamic acid sodium, the carrageen crispa and the sodium hyaluronate are compounded to form a spatial network structure and form a film, the macromolecular structure bears micromolecular moisturizers such as trehalose and amino acid, and the slow release effect is generated on the micromolecular moisturizers, so that the mask has the efficacy of long-acting moisturizing.
According to some preferred embodiments of the present invention, the ingredients and amounts of the phase C complex moisturizer are as shown in the following table:
serial number Name of raw materials Addition amount (wt%)
1 Water (W) TO100
2 Hyaluronic acid sodium salt 0.01-5.00
3 Chondrus CRISPUS (Chondrus CRISPUS) 0.01-5.00
4 Polyglutamic acid sodium salt 0.01-5.00
5 Glycerol 0.001-40.00
6 L-serine 0.01-2.00
7 L-proline 0.01-2.00
8 L-glutamic acid 0.001-0.30
9 Betaine 0.001-15.00
10 Urea 0.001-20.00
11 Pyrrolidinone carboxylic acid sodium salt 0.001-15.00
12 Trehalose 0.001-10.00
13 Preservative 0.001-1.00
14 Allantoin 0.001-0.50
15 pH regulator 0.001-5.00。
According to some embodiments of the present invention, the process for preparing the phase C composite moisturizer comprises the following steps:
(1) adding sodium polyglutamate, Chondrus crispus and sodium hyaluronate into glycerol, stirring and dispersing uniformly, adding into water, stirring, and heating to 70-90 deg.C to dissolve to obtain a first solution;
(2) adding L-serine, L-proline and L-glutamic acid into the first solution obtained in the step (1) to dissolve, adding a pH regulator to regulate the pH to 4.5-5.5, and stirring to obtain a second solution;
(3) stirring and dissolving betaine, sodium pyrrolidone carboxylate, trehalose and allantoin, and adding the mixture into the second solution obtained in the step (2);
(4) cooling to below 40 deg.C, adding urea and antiseptic, stirring, filtering, and discharging.
The inventor researches and finds that the heating temperature of the composite humectant is very important to the preparation process. When the heating temperature is lower than 60 ℃, the stability, uniformity and the like of the obtained composite humectant are poor, and when the heating temperature is higher than 70 ℃, the stability and the product state are good, and the stability, uniformity, fluidity, moldability and other properties of the composite humectant have great influence on the performance of the carrier, and the heating temperature is preferably higher than 70 ℃ in the preparation process of the composite humectant. In addition, although the solution is soluble at 95 ℃, on the one hand, the solution is prone to yellowing when heated at high temperatures for a long time, and on the other hand, the high temperatures cause energy waste for industrial production. Therefore, the preparation temperature of the compound humectant is preferably controlled to be 70-90 ℃.
Furthermore, the molecular weight selection of the macromolecular raw materials of the invention, namely the sodium polyglutamate, the sodium hyaluronate and the carrageen crispus, is very important for the film forming and slow release effects of the humectant. The smaller the molecular weight of the above-mentioned raw materials, the more difficult it is to form a stable spatial network structure, which affects the sustained-release effect and skin feel thereof. The product prepared with the larger molecular weight has better lubrication and skin feel experience, and the film forming property of the product with the larger molecular weight is better, so that the moisturizing effect of the product is more favorable. According to repeated experimental screening, researchers of the invention determine that the molecular weight of the macromolecular carrier substance of the composite humectant is as follows: the polyglutamic acid sodium is more than or equal to 50 ten thousand Da, the Phragmites communis is more than or equal to 80 ten thousand Da and the hyaluronic acid sodium is more than or equal to 5 ten thousand Da. Within the molecular weight range, a stable spatial structure can be formed and good use experience is provided, and meanwhile, the carrier structure has good performance of containing small molecular substances and good slow release performance.
According to some embodiments of the invention the sodium polyglutamate has a molecular weight of > 50 ten thousand Da, for example may be in the range of 50-300 ten thousand Da, such as 50 ten thousand Da, 80 ten thousand Da, 100 ten thousand Da, 150 ten thousand Da, 250 ten thousand Da, etc.
According to some embodiments of the invention the Chondrus crispus has a molecular weight ≧ 80 ten thousand Da, such as in the range of 80-600 ten thousand Da, such as 100 ten thousand Da, 150 ten thousand Da, 200 ten thousand Da, 500 ten thousand Da, etc.
According to some embodiments of the invention, the sodium hyaluronate is of molecular weight ≧ 5 ten thousand Da, for example, may be in the range of 5-250 ten thousand Da, such as 50 ten thousand Da, 100 ten thousand Da, 150 ten thousand Da, 190 ten thousand Da, etc.
According to a more preferred embodiment of the invention, the molecular weight of the sodium polyglutamate is 100-150 kilodaltons.
According to a more preferred embodiment of the present invention, the molecular weight of the Chondrus crispus is 150-250 ten thousand Da.
According to a more preferred embodiment of the invention, the molecular weight of the sodium hyaluronate is 100-150 ten thousand Da.
Furthermore, the moisturizing agent disclosed by the invention is compounded with other micromolecule moisturizing agent amino acids, betaine and the like through compounding of the sodium polyglutamate, the carrageen crispa and the sodium hyaluronate, so that the micromolecule moisturizing agent is slowly released, the components are synergistic, the long-acting moisturizing effect is realized, the use is good, and the moisturizing agent is the basis for the facial mask to play a long-term moisturizing effect.
According to some specific embodiments of the present invention, the thickener in phase a is a thickener acceptable in the field of skin care products, and may be one or more of sclerotium rolfsii gum, acrylic acid/C10-30 alkanol acrylate cross-linked polymer, and xanthan gum, for example.
According to some specific embodiments of the present invention, the polyol in the B phase is a polyol acceptable in the field of skin care products, and may be one or more of glycerin, butylene glycol, propylene glycol, and dipropylene glycol, for example.
According to some specific embodiments of the present invention, the anti-irritant ingredient in phase C is a substance having anti-irritant effect or a mixture thereof, which is acceptable in the field of skin care products, and may be one or more of dipotassium glycyrrhizinate, allantoin, and purslane extract, for example.
According to some embodiments of the invention, the chelating agent in phase C is a cosmetically acceptable chelating agent, such as disodium EDTA.
According to the invention, the phase C can also be added with plant extracts, wherein the plant extracts are effective plant extracts or mixtures thereof acceptable in the field of skin care products, and can be one or more of plant extracts with anti-allergy effect, plant extracts with whitening effect, plant extracts with acne-removing effect, plant extracts with anti-irritation effect and plant extracts with anti-aging effect. The content of the effective plant extract is 0-15wt% based on the total weight of the facial mask.
According to some specific embodiments of the present invention, the pH adjusting agent in phase D is a substance acceptable in the field of skin care products and having a pH adjusting function, and may be, for example, sodium hydroxide, citric acid, arginine, sodium citrate, glutamic acid.
According to some embodiments of the present invention, the phase D further includes a preservative, which is acceptable in the field of skin care products, and may be one or more of phenoxyethanol/ethylhexyl glycerin, caprylyl glycol, methylisothiazolinone/iodopropynyl butylcarbamate, etc., and the preservative may be added in a suitable amount, which is not particularly limited.
According to some embodiments of the present invention, the phase D may further include a perfume, and the perfume is acceptable in the field of skin care products, and is added in a proper amount, which is not particularly limited.
The mask can be prepared by a conventional preparation method of the mask.
The second aspect of the invention provides a preparation method of the moisturizing mask, which comprises the following steps:
(1) adding the phase A thickener into water, stirring and dissolving;
(2) dispersing the phase B uniformly, adding the dispersed phase B into the phase A mixed solution, and stirring for dissolving;
(3) respectively adding the phase C and the phase D into the mixture obtained in the step (2), and stirring;
(4) Filtering and discharging at the temperature below 38 ℃.
The facial mask comprises the following components in parts by weight:
Figure 561912DEST_PATH_IMAGE002
according to the invention, the components and the dosage of the B-phase long-acting compound humectant are as follows:
name of raw materials Addition amount (wt%)
Water (W) TO100
Hyaluronic acid sodium salt 0.01-5.00
Chondrus CRISPUS (Chondrus CRISPUS) 0.01-5.00
Polyglutamic acid sodium salt 0.01-5.00
Glycerol 0.001-40.00
L-serine 0.01-2.00
L-proline 0.00-2.00
L-glutamic acid 0.00-0.30
Betaine 0.001-15.00
Urea 0.00-20.00
Pyrrolidinone carboxylic acid sodium salt 0.001-15.00
Trehalose 0.00-10.00
Preservative 0.00-1.00
Allantoin 0.001-0.50
pH regulator 0.001-5.00,
According to some preferred embodiments of the present invention, the ingredients and amounts of the phase B complex moisturizer are as follows:
serial number Name of raw materials Addition amount (wt%)
1 Water (W) TO100
2 Hyaluronic acid sodium salt 0.01-5.00
3 Chondrus CRISPUS (Chondrus CRISPUS) 0.01-5.00
4 Polyglutamic acid sodium salt 0.01-5.00
5 Glycerol 0.001-40.00
6 L-serine 0.01-2.00
7 L-proline 0.01-2.00
8 L-glutamic acid 0.001-0.30
9 Betaine 0.001-15.00
10 Urea 0.001-20.00
11 Pyrrolidinone carboxylic acid sodium salt 0.001-15.00
12 Trehalose 0.001-10.00
13 Preservative 0.001-1.00
14 Allantoin 0.001-0.50
15 pH regulator 0.001-5.00。
According to some embodiments of the present invention, the preparation process of the B-phase composite humectant comprises the following steps:
(1) adding sodium polyglutamate, Chondrus crispus and sodium hyaluronate into glycerol, stirring and dispersing uniformly, adding into water, stirring, and heating to 70-90 deg.C to dissolve to obtain a first solution;
(2) adding L-serine, L-proline and L-glutamic acid into the first solution obtained in the step (1) to dissolve, adding a pH regulator to regulate the pH to 4.5-5.5, and stirring to obtain a second solution;
(3) Stirring and dissolving betaine, sodium pyrrolidone carboxylate, trehalose and allantoin, and adding the mixture into the second solution obtained in the step (2);
(4) cooling to below 40 deg.C, adding urea and antiseptic, stirring, filtering, and discharging.
According to some embodiments of the invention the sodium polyglutamate has a molecular weight of > 50 ten thousand Da, for example may be in the range of 50-300 ten thousand Da, such as 50 ten thousand Da, 80 ten thousand Da, 100 ten thousand Da, 150 ten thousand Da, 250 ten thousand Da, etc.
According to some embodiments of the invention the Chondrus crispus has a molecular weight ≧ 80 ten thousand Da, such as in the range of 80-600 ten thousand Da, such as 100 ten thousand Da, 150 ten thousand Da, 200 ten thousand Da, 500 ten thousand Da, etc.
According to some embodiments of the invention, the sodium hyaluronate is of molecular weight ≧ 5 ten thousand Da, for example, may be in the range of 5-250 ten thousand Da, such as 50 ten thousand Da, 100 ten thousand Da, 150 ten thousand Da, 190 ten thousand Da, etc.
According to a more preferred embodiment of the invention, the molecular weight of the sodium polyglutamate is 100-150 kilodaltons.
According to a more preferred embodiment of the present invention, the molecular weight of the Chondrus crispus is 150-250 ten thousand Da.
According to a more preferred embodiment of the invention, the molecular weight of the sodium hyaluronate is 100-150 ten thousand Da.
According to some embodiments of the present invention, the thickener in phase A is a thickener acceptable in the skin care field, and may be, for example, sclerotium rolfsii gum, acrylic acid/C10-30 alkanol acrylate crosspolymer, xanthan gum, or a mixture thereof.
According to some embodiments of the invention, the polyol in phase B is a skin care acceptable polyol, and may be, for example, glycerin, butylene glycol, propylene glycol, dipropylene glycol, or mixtures thereof.
According to some specific embodiments of the present invention, the anti-irritant ingredient in phase C is a substance having anti-irritant effect or a mixture thereof, which is acceptable in the field of skin care products, and may be one or more of dipotassium glycyrrhizinate, allantoin, and purslane extract, for example.
According to some embodiments of the invention, the chelating agent in phase C is a cosmetically acceptable chelating agent, such as disodium EDTA.
According to other embodiments of the present invention, the C phase may further comprise other functional plant extracts or mixtures thereof acceptable in the field of skin care products, for example, one or more of plant extract with anti-allergy function, plant extract with whitening function, plant extract with anti-acne function, plant extract with anti-irritation function and plant extract with anti-aging function. The content of the effective plant extract is 0-15wt% based on the total weight of the facial mask.
According to some specific embodiments of the present invention, the pH adjusting agent in phase D is a substance acceptable in the field of skin care products and having a pH adjusting function, and may be, for example, sodium hydroxide, citric acid, arginine, sodium citrate, glutamic acid.
According to some embodiments of the present invention, the phase D further includes a preservative, which is acceptable in the field of skin care products, and may be one or more of phenoxyethanol/ethylhexyl glycerin, caprylyl glycol, and the like, without being limited thereto.
According to some embodiments of the present invention, the phase D may further include a perfume, which is acceptable in the field of skin care products, and is not particularly limited.
In a third aspect, the present invention provides a facial mask obtained by the method of the second aspect of the present invention.
Compared with the prior art, the invention has the beneficial effects that at least:
(1) the carrier performance of the facial mask system composite humectant enables the micromolecular humectant to be slowly released, the moisturizing effect of the humectant is fully exerted, and the obvious and lasting moisturizing effect is achieved; meanwhile, the good film-forming property of the macromolecular substances further enhances the moisturizing effect of the mask.
(2) The mask disclosed by the invention can play a good moisturizing effect in the aspects of short-term and long-term moisturizing, has good skin feel, still generates the moisturizing effect after the product is stopped, and has good application value;
(3) the facial mask disclosed by the invention has the advantages that the humectant components are efficiently utilized, and the bioavailability of the humectant components is improved.
Drawings
FIG. 1 is a diagram showing the results of the film-forming experiment of the macromolecular complex of the present invention;
FIG. 2 shows the results of the 48h mean change rate test of skin moisture content of the mask prepared according to example 16; preparing a test result of the mean change rate of skin moisture content of the mask for 48 hours according to the comparative example 6; according to the result of the test of the average change rate of the skin moisture content of 48h of the commercial mask competitive products;
FIG. 3 shows the results of the mean change rate test of skin moisture content after mask 21d and disuse prepared according to example 16; preparing a mask 21d according to comparative example 6 and a skin moisture content mean value change rate test result after the mask is stopped; and testing results according to the commercial mask competitive product 21d and the average change rate of the skin moisture content after the mask is stopped.
The specific implementation mode is as follows:
in order to further explain the technical means adopted by the present invention and the effects thereof, the present invention is further explained by combining with the embodiments below. It is to be understood that the specific embodiments described herein are merely illustrative of the invention and are not limiting of the invention. The examples, which are not specifically shown for the specific methods, are all routine in the art or according to the product specifications. The reagents or apparatus used are conventional products commercially available from normal sources, not indicated by the manufacturer.
Table 1 raw materials supplier list
Name of raw materials INCI name Raw materials supplier
Water (W) Water (W) Yibao (good health)
Sclerotium rolfsii gum SCLEROTIUM rolfsii (scleritium rolfsii) glue Lu bo run
Hyaluronic acid sodium salt Hyaluronic acid sodium salt Huaxi Rui Da
Glycerine Glycerol Chemical industry for treasure
Glycyrrhizic acid dipotassium salt Glycyrrhizic acid dipotassium salt Shanghai Aoli
EDTA-2Na EDTA disodium salt Aksu
NaOH Sodium hydroxide Chemical industry of Xilong
Microcare PEHG Phenoxyethanol/ethylhexyl glycerin Tuo Er
Essence Essence Weisi sand
Hyaluronic acid sodium salt Hyaluronic acid sodium salt Furuida preparation
Viscarin PC 209 Chondrus CRISPUS (Chondrus CRISPUS) (DuPont)
Polyglutamic acid Polyglutamic acid Furuida preparation
Glycerol Glycerol Baojie medicine
L-Serine Serine Tin-free crystal sea
L-Proline Proline Tin-free crystal sea
L-Glutamic acid Glutamic acid Tin-free crystal sea
NUTRI BETAINE Betaine Vast Sen International
Urea Urea Kangpuhuiwei
NL-50 Pyrrolidinone Carboxylic acid sodium salt PCA sodium salt Gourmet powder
Trehalose Trehalose Japanese forest source
Microcare Emollient CLG Octylene glycol Tuo Er
Allantoin Allantoin Yashilan
TABLE 2 Instrument information List
Name of instrument Specification and model Manufacturer of the product
Sadoris electronic balance BSA2202S-CW Sadoris sp
Mettler electronic balance ML204/02 Mettlerlatido
Stirrer IKA continental star IKA
Electric ceramic stove LC-E109S Guangdong moral and shun electrical equipment
Examples 1-15 preparation of composite moisturizer
Example 1:
1) adding 0.3 part by weight of sodium polyglutamate (molecular weight of 100 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 200 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (molecular weight of 100 ten thousand Da) into 35 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 80 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) Weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1), dissolving, adding L-glutamic acid, adjusting the pH value to 4.5-5.5, and uniformly stirring at a stirrer rotating speed of 300 r/min;
3) weighing 4 parts by weight of betaine, 6 parts by weight of sodium pyrrolidone carboxylate, 4 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding the obtained solution in the step 2);
4) cooling to below 40 ℃, adding 8 parts by weight of urea and 0.4 part by weight of preservative octyl glycol, stirring uniformly, filtering and discharging.
Example 2:
1) adding 0.3 part by weight of sodium polyglutamate (molecular weight of 100 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 200 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (molecular weight of 100 ten thousand Da) into 35 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 80 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 6 parts by weight of sodium pyrrolidone carboxylate, 4 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) Cooling to below 40 ℃, adding 0.4 weight part of preservative octyl glycol, stirring uniformly, filtering and discharging.
Example 3:
1) adding 0.3 part by weight of sodium polyglutamate (molecular weight of 100 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 200 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (molecular weight of 100 ten thousand Da) into 40 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 80 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine and 6 parts by weight of sodium pyrrolidone carboxylate, and adding the mixture into the solution obtained in the step 2), stirring and dissolving;
4) cooling to below 40 ℃, adding 0.4 weight part of preservative octyl glycol, stirring uniformly, filtering and discharging.
Example 4:
1) adding 0.3 part by weight of sodium polyglutamate (with a molecular weight of 50 ten thousand Da), 2 parts by weight of Chondrus crispus (with a molecular weight of 80 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (with a molecular weight of 50 ten thousand Da) into 35 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at a stirrer rotating speed of 300r/min, and simultaneously heating to 85 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) Weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 6 parts by weight of sodium pyrrolidone carboxylate, 4 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding the obtained solution in the step 2);
4) cooling to below 40 ℃, adding 8 parts by weight of urea and 0.4 part by weight of preservative octylene glycol, stirring uniformly, filtering and discharging.
Example 5:
1) adding 0.3 part by weight of sodium polyglutamate (molecular weight of 150 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 150 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (molecular weight of 150 ten thousand Da) into 35 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of a stirrer of 300r/min, and simultaneously heating to 75 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 6 parts by weight of sodium pyrrolidone carboxylate, 4 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding the obtained solution in the step 2);
4) Cooling to below 40 ℃, adding 8 parts by weight of urea and 0.4 part by weight of preservative octylene glycol, stirring uniformly, filtering and discharging.
Example 6:
1) adding 0.3 part by weight of sodium polyglutamate (molecular weight of 100 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 150 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (molecular weight of 150 ten thousand Da) into 35 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 80 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 6 parts by weight of sodium pyrrolidone carboxylate, 4 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding the obtained solution in the step 2);
4) cooling to below 40 ℃, adding 8 parts by weight of urea and 0.4 part by weight of preservative octylene glycol, stirring uniformly, filtering and discharging.
Example 7:
1) adding 0.3 part by weight of sodium polyglutamate (molecular weight of 80 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 200 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (molecular weight of 100 ten thousand Da) into 35 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 85 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) Weighing 1.2 parts by weight of L-serine and 0.6 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 6 parts by weight of sodium pyrrolidone carboxylate, 4 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding the obtained solution in the step 2);
4) cooling to below 40 ℃, adding 8 parts by weight of urea and 0.4 part by weight of preservative octyl glycol, stirring uniformly, filtering and discharging.
Example 8:
1) adding 1 weight part of sodium polyglutamate (molecular weight is 50 ten thousand Da), 0.01 weight part of Chondrus crispus (molecular weight is 200 ten thousand Da) and 1 weight part of sodium hyaluronate (molecular weight is 100 ten thousand Da) into 15 weight parts of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 80 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 2 parts by weight of L-serine and 2 parts by weight of L-proline, adding into the medium obtained in the step 1), dissolving, adding L-glutamic acid, adjusting the pH value to 4.5-5.5, and uniformly stirring at a stirrer rotating speed of 300 r/min;
3) weighing 10 parts by weight of betaine, 10 parts by weight of sodium pyrrolidone carboxylate, 10 parts by weight of trehalose and 0.5 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) Cooling to below 40 ℃, adding 20 parts by weight of urea and 0.3 part by weight of preservative octylene glycol, stirring uniformly, filtering and discharging.
Example 9:
1) adding 0.2 part by weight of sodium polyglutamate (with the molecular weight of 250 ten thousand Da), 5 parts by weight of Chondrus crispus (with the molecular weight of 200 ten thousand Da) and 0.2 part by weight of sodium hyaluronate (with the molecular weight of 100 ten thousand Da) into 40 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 80 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 1 part by weight of L-serine and 0.5 part by weight of L-proline, adding into the solution obtained in the step 1) for dissolving, adding L-glutamic acid to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of 300r/min of a stirrer;
3) weighing 5 parts by weight of betaine, 5 parts by weight of sodium pyrrolidone carboxylate, 10 parts by weight of trehalose and 0.1 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) cooling to below 40 ℃, adding 10 parts by weight of urea and 0.3 part by weight of preservative octylene glycol, stirring uniformly, filtering and discharging.
Example 10:
1) adding 0.2 weight part of sodium polyglutamate (molecular weight of 100 ten thousand Da), 1 weight part of Chondrus crispus (molecular weight of 100 ten thousand Da) and 0.1 weight part of sodium hyaluronate (molecular weight of 100 ten thousand Da) into 20 weight parts of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 75 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) Weighing 0.01 part by weight of L-serine and 0.5 part by weight of L-proline, adding into the solution obtained in the step 1), dissolving, adding L-glutamic acid, adjusting the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of 300r/min by using a stirrer;
3) weighing 5 parts by weight of betaine, 5 parts by weight of sodium pyrrolidone carboxylate, 5 parts by weight of trehalose and 0.2 part by weight of allantoin, stirring and dissolving, and adding the mixture into the solution obtained in the step 2);
4) cooling to below 40 ℃, adding 5 parts by weight of urea and 0.5 part by weight of preservative octylene glycol, stirring uniformly, filtering and discharging.
Example 11:
1) adding 2 parts by weight of sodium polyglutamate (molecular weight of 100 ten thousand Da), 2 parts by weight of Chondrus crispus (molecular weight of 500 ten thousand Da) and 2 parts by weight of sodium hyaluronate (molecular weight of 100 ten thousand Da) into 40 parts by weight of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of a stirrer of 300r/min, and simultaneously heating to 85 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 1 part by weight of L-serine, 0.01 part by weight of L-proline and 0.1 part by weight of L-glutamic acid, adding into the solution obtained in the step 1) for dissolving, adding citric acid and sodium hydroxide to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 5 parts by weight of betaine, 3 parts by weight of sodium pyrrolidone carboxylate, 5 parts by weight of trehalose and 0.1 part by weight of allantoin, stirring and dissolving, and adding the mixture into the solution obtained in the step 2);
4) Cooling to below 40 deg.C, adding urea 10 weight parts and antiseptic phenoxyethanol/ethylhexyl glycerol 0.8 weight parts, stirring, filtering, and discharging.
Example 12:
1) adding 1 weight part of poly-sodium glutamate (molecular weight 100 ten thousand Da), 1 weight part of Chondrus crispus (molecular weight 80 ten thousand Da) and 1 weight part of sodium hyaluronate (molecular weight 100 ten thousand Da) into 10 weight parts of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of a stirrer of 300r/min, and simultaneously heating to 70 ℃ until the solution is completely dissolved;
2) weighing 1.5 parts by weight of L-serine, 1 part by weight of L-proline and 0.1 part by weight of L-glutamic acid, adding into the solution obtained in the step 1) for dissolving, adding citric acid and sodium hydroxide to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 5 parts by weight of betaine, 5 parts by weight of sodium pyrrolidone carboxylate, 0.5 part by weight of trehalose and 0.1 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) cooling to below 40 deg.C, adding 5 weight parts of urea and 0.8 weight part of antiseptic phenoxyethanol/ethylhexyl glycerol, stirring, filtering, and discharging.
Example 13:
1) adding 0.01 weight part of sodium polyglutamate (molecular weight of 100 ten thousand Da), 3 weight parts of Chondrus crispus (molecular weight of 200 ten thousand Da) and 0.01 weight part of sodium hyaluronate (molecular weight of 5 ten thousand Da) into 8 weight parts of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 90 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) Weighing 0.8 part by weight of L-serine, 1.8 parts by weight of L-proline and 0.1 part by weight of L-glutamic acid, adding into the solution obtained in the step 1), dissolving, adding citric acid and sodium hydroxide to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 0.2 part by weight of sodium pyrrolidone carboxylate, 1 part by weight of trehalose and 0.01 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) cooling to below 40 deg.C, adding 1 weight part of urea and 0.8 weight part of antiseptic phenoxyethanol/ethylhexyl glycerol, stirring, filtering, and discharging.
Example 14:
1) adding 0.01 weight part of sodium polyglutamate (molecular weight is 80 ten thousand Da), 3 weight parts of Chondrus crispus (molecular weight is 80 ten thousand Da) and 0.01 weight part of sodium hyaluronate (molecular weight is 50 ten thousand Da) into 8 weight parts of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 85 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 0.8 part by weight of L-serine, 1.8 parts by weight of L-proline and 0.1 part by weight of L-glutamic acid, adding into the solution obtained in the step 1), dissolving, adding citric acid and sodium hydroxide to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) Weighing 4 parts by weight of betaine, 0.2 part by weight of sodium pyrrolidone carboxylate, 1 part by weight of trehalose and 0.01 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) cooling to below 40 deg.C, adding 1 weight part of urea and 0.8 weight part of antiseptic phenoxyethanol/ethylhexyl glycerol, stirring, filtering, and discharging.
Example 15:
1) adding 0.01 weight part of sodium polyglutamate (molecular weight is 50 ten thousand Da), 3 weight parts of Chondrus crispus (molecular weight is 80 ten thousand Da) and 0.01 weight part of sodium hyaluronate (molecular weight is 190 ten thousand Da) into 8 weight parts of glycerin, stirring and dispersing uniformly, adding into water, stirring at the rotating speed of 300r/min by using a stirrer, and simultaneously heating to 85 ℃ until the sodium polyglutamate, the Chondrus crispus and the sodium hyaluronate are completely dissolved;
2) weighing 0.8 part by weight of L-serine, 1.8 parts by weight of L-proline and 0.1 part by weight of L-glutamic acid, adding into the solution obtained in the step 1), dissolving, adding citric acid and sodium hydroxide to adjust the pH value to 4.5-5.5, and uniformly stirring at the rotating speed of a stirrer of 300 r/min;
3) weighing 4 parts by weight of betaine, 0.2 part by weight of sodium pyrrolidone carboxylate, 1 part by weight of trehalose and 0.01 part by weight of allantoin, stirring and dissolving, and adding into the solution obtained in the step 2);
4) cooling to below 40 deg.C, adding 1 weight part of urea and 0.8 weight part of antiseptic phenoxyethanol/ethylhexyl glycerol, stirring, filtering, and discharging.
Examples 16 to 24: preparation of facial mask
Examples 16-24 masks were all prepared by the following preparation process:
(1) adding the phase A into water, stirring and dissolving;
(2) dispersing phase B uniformly, adding phase A, stirring and dissolving;
(3) respectively adding the phase C and the phase D into the mixture obtained in the step (2), and stirring;
(4) filtering and discharging at the temperature below 38 ℃.
Example 16:
the components and the dosage are as follows:
Figure 76070DEST_PATH_IMAGE003
example 17:
the components and the dosage are as follows:
Figure 2438DEST_PATH_IMAGE004
example 18:
the components and the dosage are as follows:
Figure 488914DEST_PATH_IMAGE005
example 19:
the components and the dosage are as follows:
Figure 842535DEST_PATH_IMAGE006
example 20:
the components and the dosage are as follows:
Figure 843989DEST_PATH_IMAGE007
example 21:
the components and the dosage are as follows:
Figure 446484DEST_PATH_IMAGE008
example 22:
the components and the dosage are as follows:
Figure 646521DEST_PATH_IMAGE009
example 23:
the components and the dosage are as follows:
Figure 311989DEST_PATH_IMAGE010
example 24:
the components and the dosage are as follows:
Figure 597477DEST_PATH_IMAGE011
comparative examples 1 to 6
Comparative example 1:
components and amounts thereof
Figure 68909DEST_PATH_IMAGE013
Comparative example 2:
components and amounts thereof
Figure 795557DEST_PATH_IMAGE015
Comparative example 3:
components and amounts thereof
Figure 631926DEST_PATH_IMAGE017
Comparative example 4:
components and amounts thereof
Figure 404710DEST_PATH_IMAGE019
Comparative example 5:
components and amounts thereof
Figure 414254DEST_PATH_IMAGE021
Comparative example 6:
components and amounts thereof
Figure 464250DEST_PATH_IMAGE023
Efficacy evaluation test
First, off-line state observation and skin feel stability test
The masks prepared in example 16 and comparative examples 1-6 were observed for off-line condition and skin feel stability, and the results are shown in the following table:
Figure 330575DEST_PATH_IMAGE024
according to the off-line product state and skin feel observation results, the facial masks of example 16 and comparative example 6 have proper consistency and good skin feel; comparative examples 1 to 3 are thin in consistency and have dripping phenomenon when in use; comparative examples 4 and 5 were thick in the use state, thick and sticky in the facial skin.
Film-forming property
Adding 0.3 weight part of sodium polyglutamate (molecular weight of 100 ten thousand Da), 2 weight parts of Chondrus crispus (molecular weight of 200 ten thousand Da) and 0.2 weight part of sodium hyaluronate (molecular weight of 100 ten thousand Da) into water, and heating to 80 ℃ until the mixture is dissolved to obtain a mixed solution (macromolecular compound part of the composite humectant). The mixed solution was spread on a glass slide and dried to obtain the results shown in FIG. 1.
The facial mask C-phase composite humectant disclosed by the invention contains three macromolecular substances, namely sodium polyglutamate, sodium hyaluronate and carrageen crispus, and forms a stable space network structure after being mixed, as can be seen from figure 1, the structure can form an invisible film on the surface of skin, so that the moisture and moisturizing components cannot be rapidly lost due to the existence of a molecular film after a facial mask cloth is removed, and a moisturizing effect is achieved, and the facial mask C-phase composite humectant is a structural basis for realizing a long-acting moisturizing effect.
Evaluation of short-term and long-term moisturizing effect
Experiment one: moisturizing experiment for 48h
And (3) testing a sample:
example 16 mask, comparative example 6 mask, certain commercially available moisturizing mask products (main ingredients were water, butylene glycol, glyceryl polyether-26, sodium hyaluronate, betaine, allantoin, dipotassium glycyrrhizinate, carbomer, amino acids, etc.).
The experimental method comprises the following steps:
36 qualified subjects were screened, and 12 persons were divided into three groups, and the moisturizing efficacy test was performed using the mask samples of example 16, a commercially available competitive product, and comparative example 6, respectively.
Volunteers measured the initial skin moisture content of the cheeks after sitting still in a constant humidity and temperature room for 1 h. After 15min of application of the test sample to the face, the moisture content of the cheek skin was measured after 2 hours, 4 hours, 6 hours, 8 hours, 24 hours, and 48 hours after application of the sample, and the test results are shown in fig. 2.
Within 48 hours after application of the test samples, the rate of homogeneous change in cheek skin moisture content from the initial value was significantly higher for the subjects who applied the moisturizing mask of example 16 than for the subjects who applied the moisturizing mask of the comparative example 6. Therefore, the facial mask of the invention can achieve the effect of instant and long-acting moisturizing for 48 hours.
Experiment two: 21d human body moisturizing experiment
And (3) testing a sample:
example 16 mask, comparative example 6 mask, some commercially available moisturizing product (main ingredients were water, butylene glycol, glyceryl polyether-26, sodium hyaluronate, betaine, allantoin, dipotassium glycyrrhizinate, carbomer, amino acid, etc.).
The experimental method comprises the following steps:
36 qualified subjects were screened, and 12 persons were divided into three groups, and the moisturizing efficacy test was performed using each of example 16, comparative example 6, and a commercially available pack for auction.
Volunteers measured the initial skin moisture content of the cheeks after sitting still in a constant humidity and temperature room for 1 h. The test sample was applied to the face for 15min every other day and night for 21d, and the use of the test sample was stopped after 21 d. Cheek skin hydration was tested at 21d after sample application and at 2d, 5d after sample withdrawal.
The test results are shown in fig. 3:
after 21 days of use of the test samples, the mean rate of change of the moisture content of the cheek skin was significantly higher in the group of subjects using the moisturizing mask of example 16 than in the group of subjects using the moisturizing mask of comparative example 6, and within 5 days of the rest of the samples, the mean rate of change of the moisture content of the cheek skin was significantly higher in the group of subjects using the moisturizing mask of example 16 than in the other two groups.
In conclusion, the moisturizing mask disclosed by the invention can effectively increase the moisture of the skin, can achieve the effect of keeping the moisture of the skin for a long time, and has excellent instant and long-acting moisturizing effects.

Claims (10)

1. The moisture mask is characterized by comprising the following components in parts by weight:
addition amount (wt%) of phase-group raw material name
TO 100A Water
0.05-0.50 of thickening agent
0 to 0.2 percent of sodium hyaluronate
Polyol 3.00-10.00
C anti-irritant component 0-0.50
0.50-10.00% of compound humectant
Chelating agent 0.00-0.30
D, 0 to 0.50 of pH regulator,
the C-phase composite humectant comprises the following components in percentage by weight:
raw material name addition amount (wt%)
Water TO100
0.01-5.00 g of sodium hyaluronate
Chondrus CRISPUS (Chondrus CRISPUS) 0.01-5.00
0.01-5.00% of sodium polyglutamate
Glycerin 0.001-40.00
L-serine 0.01-2.00
L-proline 0.00-2.00
L-glutamic acid 0.00-0.30
Betaine 0.001-15.00
Urea 0.00-20.00
Pyrrolidone carboxylic acid sodium 0.001-15.00
Trehalose 0.00-10.00
Antiseptic 0.00-1.00
Allantoin 0.001-0.50
pH regulator 0.001-5.00.
2. The mask of claim 1, wherein the phase C composite moisturizer comprises the following components in parts by weight:
raw material name addition amount (wt%)
Water TO100
0.01-5.00 g of sodium hyaluronate
Chondrus CRISPUS (Chondrus CRISPUS) 0.01-5.00
0.01-5.00% of sodium polyglutamate
Glycerin 0.001-40.00
L-serine 0.01-2.00
L-proline 0.01-2.00
L-glutamic acid 0.001-0.30
Betaine 0.001-15.00
0.001-20.00% of urea
Pyrrolidone carboxylic acid sodium 0.001-15.00
Trehalose 0.001-10.00
0.001-1.00% of preservative
Allantoin 0.001-0.50
pH regulator 0.001-5.00.
3. The mask of claim 1 or 2, wherein the phase C complex moisturizer is prepared by a method comprising the steps of:
(1) adding sodium polyglutamate, Chondrus crispus and sodium hyaluronate into glycerol, stirring and dispersing uniformly, adding into water, stirring, and heating to 70-90 deg.C to dissolve to obtain a first solution;
(2) adding L-serine, L-proline and L-glutamic acid into the first solution obtained in the step (1) to dissolve, adding a pH regulator to regulate the pH to 4.5-5.5, and stirring to obtain a second solution;
(3) stirring and dissolving betaine, sodium pyrrolidone carboxylate, trehalose and allantoin, and adding the mixture into the second solution obtained in the step (2);
(4) cooling to below 40 deg.C, adding urea and antiseptic, stirring, filtering, and discharging.
4. A mask according to any one of claims 1 to 3 wherein the molecular weight of the sodium polyglutamate is greater than or equal to 50 million Da, and/or the molecular weight of the Chondrus crispus is greater than or equal to 80 million Da, and/or the molecular weight of the sodium hyaluronate is greater than or equal to 5 million Da; preferably, the molecular weight of the sodium polyglutamate is not less than 100 ten thousand Da, and/or the molecular weight of the Chondrus crispus is not less than 200 ten thousand Da, and/or the molecular weight of the sodium hyaluronate is not less than 100 ten thousand Da.
5. The mask according to any one of claims 1 to 4, wherein the thickener in phase A is a thickener acceptable in the field of skin care products, and is preferably one or more of sclerotium rolfsii gum, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer and xanthan gum; and/or the polyhydric alcohol in the B phase is a polyhydric alcohol acceptable in the field of skin care products, preferably one or more of glycerol, butanediol, propylene glycol and dipropylene glycol; and/or the anti-irritation component in the C phase is a substance or a mixture thereof with anti-irritation effect acceptable in the field of skin care products, preferably one or more of dipotassium glycyrrhizinate, allantoin and purslane extracts, and/or the chelating agent in the C phase is a chelating agent acceptable in the field of skin care products, preferably disodium EDTA.
6. The mask of any one of claims 1 to 5, wherein phase C further comprises a plant extract, wherein the plant extract is a cosmetically acceptable plant extract or a mixture thereof.
7. The mask of claim 6, wherein the plant extract is added in an amount of 0.00-15.00 wt%.
8. The mask of any one of claims 1 to 7 wherein the phase D pH adjusting agent is a pH adjusting agent acceptable in the field of skin care products, preferably sodium hydroxide, citric acid, arginine, sodium citrate, glutamic acid; and/or the phase D also comprises a proper amount of preservative, wherein the preservative is acceptable in the field of cosmetics, and is preferably phenoxyethanol/ethylhexyl glycerin; and/or the phase D also comprises a proper amount of essence.
9. A preparation method of a moisturizing mask is characterized by comprising the following steps:
(1) adding the phase A thickener of claim 1 or 5 into water, and stirring to dissolve;
(2) dispersing the phase B of claim 1 or 5 uniformly, adding into the phase A mixed solution, stirring and dissolving;
(3) adding the phase C according to any one of claims 1 or 5 to 6 and the phase D according to claim 1 or 8 to the mixture obtained in step (2), and stirring;
(4) filtering and discharging at the temperature below 38 ℃.
10. A moisture-retaining mask prepared by the method of claim 9.
CN201910704721.3A 2019-07-31 2019-07-31 Moisture mask and preparation method thereof Active CN112294705B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910704721.3A CN112294705B (en) 2019-07-31 2019-07-31 Moisture mask and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910704721.3A CN112294705B (en) 2019-07-31 2019-07-31 Moisture mask and preparation method thereof

Publications (2)

Publication Number Publication Date
CN112294705A CN112294705A (en) 2021-02-02
CN112294705B true CN112294705B (en) 2022-07-29

Family

ID=74485406

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910704721.3A Active CN112294705B (en) 2019-07-31 2019-07-31 Moisture mask and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112294705B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114246811A (en) * 2021-09-03 2022-03-29 太和康美(北京)中医研究院有限公司 Skin moisturizer with moisturizing effect and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105030564A (en) * 2015-08-18 2015-11-11 广东轻工职业技术学院 Composition with long-lasting moisturizing function and application of composition
EP3413816A1 (en) * 2016-02-12 2018-12-19 Rodan & Fields LLC Moisturizing compositions and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105030564A (en) * 2015-08-18 2015-11-11 广东轻工职业技术学院 Composition with long-lasting moisturizing function and application of composition
EP3413816A1 (en) * 2016-02-12 2018-12-19 Rodan & Fields LLC Moisturizing compositions and uses thereof

Also Published As

Publication number Publication date
CN112294705A (en) 2021-02-02

Similar Documents

Publication Publication Date Title
CN112294704B (en) Shampoo and preparation method thereof
CN109172388A (en) Ceramide III containing liposome has anti-aging, the facial mask liquid of sebum barrier reparation and preparation method thereof
CN107440932B (en) Skin care product composition containing folic acid, facial mask and preparation method of facial mask
CN112294705B (en) Moisture mask and preparation method thereof
CN110237006B (en) Skin care composition and mask
CN111297787A (en) Hyaluronic acid water-moistening mask
CN114931543A (en) Repair anti-aging essence with high content of blue copper peptide and preparation method thereof
CN109381348B (en) Stable transparent toning lotion with high collagen content
CN110279626A (en) With the cosmetic composition and preparation method thereof for cooperateing with long-acting moistening effect
CN113350221A (en) A skin care composition for resisting aging and its preparation method
CN114099408A (en) A composition containing prebiotics, probiotics and metazoan, and its preparation method
CN107920971B (en) Scalp composition, scalp cosmetic preparation, and method for applying scalp composition
CN108210442A (en) Skin care compositions of mild high nutrition and its preparation method and application
CN116889528A (en) Water-light mask and preparation method thereof
CN115634175B (en) Composition for preparing microbead essence, microbead essence and preparation method of microbead essence
CN109528579B (en) Moisturizing and repairing emulsion spray and preparation method thereof
CN110787106A (en) Plant revitalizing and purifying composition and preparation method thereof
CN107693386B (en) Man skin care product composition and application thereof
CN112294706B (en) Moisturizing composition and preparation method and application thereof
CN111728894B (en) Protective cream and preparation process thereof
CN114246811A (en) Skin moisturizer with moisturizing effect and preparation method thereof
CN113520914A (en) Retinol sleeping mask and preparation method thereof
CN115006303A (en) Anti-allergy moisturizing skin-activating essence lotion and preparation method thereof
CN112294707B (en) Cream with moisturizing effect and preparation method thereof
CN115624508A (en) Skin care composition and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant